Anaphylaxis: can we tell who is at risk of a fatal reaction?
about
Food allergy: recent advances in pathophysiology and treatmentAllergy and the cardiovascular systemManaging nut-induced anaphylaxis: challenges and solutionsGuidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panelPharmacists' response to anaphylaxis in the community (PRAC): a randomised, simulated patient study of pharmacist practice.Update on the usage and safety of epinephrine auto-injectors, 2017.Multifactorial Modulation of Food-Induced AnaphylaxisThe utility of serum tryptase in the diagnosis of food-induced anaphylaxis.Anaphylaxis avoidance and management: educating patients and their caregivers.Using 'may contain' labelling to inform food choice: a qualitative study of nut allergic consumersMultiple epinephrine doses for stinging insect hypersensitivity reactions treated in the emergency department.Anaphylaxis treatment: current barriers to adrenaline auto-injector use.Improving diagnostic accuracy of anaphylaxis in the acute care setting.Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associationsInternational survey of knowledge of food-induced anaphylaxis.Direct evidence for the formation of diastereoisomeric benzylpenicilloyl haptens from benzylpenicillin and benzylpenicillenic acid in patients.Identification of risk factors of severe hypersensitivity reactions in general anaesthesiaAnaphylaxis: clinical concepts and research priorities.Multicenter study of repeat epinephrine treatments for food-related anaphylaxisEight years of severe allergic reactions in Finland: a register-based report.Epinephrine: the drug of choice for anaphylaxis-a statement of the world allergy organization.Anaphylaxis to foods.Ara h 1 CD4+ T cell epitope-based peptides: candidates for a peanut allergy therapeuticApproaches to establish thresholds for major food allergens and for gluten in food.Clinical immunology review series: an approach to the patient with anaphylaxis.Anaphylaxis in the community: a questionnaire survey of members of the UK Anaphylaxis Campaign.Risk of anaphylaxis in opioid dependent persons: effects of heroin versus substitution substance.Allergies in Asia: differences in prevalence and management compared with western populations.Consumer preferences for food allergen labeling.Educational case series: Mechanisms of drug allergy.Update on food allergy in adults.Drug-induced anaphylaxis: a decade review of reporting to the Portuguese Pharmacovigilance Authority.Oral food challenge: safety, adherence to guidelines and predictive value of skin prick testing.IgE mediated food allergy in Korean children: focused on plant food allergy.Egg allergy: an update.Optimal treatment of anaphylaxis: antihistamines versus epinephrine.Food allergy, a summary of eight cases in the UK criminal and civil courts: effective last resort for vulnerable consumers?Developing therapies for peanut allergy.Anaphylaxis attributed to exercise: considerations for sports medicine specialists.Managing patients with side effects and adverse events to immunoglobulin therapy.
P2860
Q24633951-016B8037-881D-4D89-A388-4C6EB51EFA4FQ24644929-909D83BC-560D-4331-92B7-677E96FFB372Q26775864-67079D94-5923-4987-A55D-837BB4A5F292Q28300001-8BB4B30D-9BED-4627-BC45-190167EB2BCBQ30209397-15A82AF0-AE43-46AE-9910-1EBD33AA036BQ30400473-0142D5C5-4647-4127-9AD4-453C1183985AQ33690086-3ED2C85F-D3AA-4766-806E-3218403C297EQ33831572-BAE00844-1F89-44B4-8751-71CCEC0C7D6AQ33895403-873100A3-D4CC-4F74-B111-41FDCEF02317Q34029303-EB5A2254-E51B-4024-B828-37535CA07D75Q34056753-81DD70B5-55E7-4940-9278-1F299AA20C15Q34420331-59B04D8D-EC80-4690-9200-8A6F9990FD27Q34522907-C23B663B-F13B-433D-8CD2-7DD113614EEBQ34663681-D24C87B7-B9D7-48A1-9A88-768A7D883D0DQ34995756-C75652C7-8C3F-4F23-BA2C-C187F5017ED9Q35188174-AA515370-808E-4492-B6B1-406CBD07DBFDQ35764873-FBA38280-CDCD-4B39-BEAA-C8B8AE6BF2B8Q36466735-0694D2A5-A24D-4B24-91F0-8E64EB2FC83FQ36492714-E2C88976-EB2C-4A93-AEBC-C04DC1B009C0Q36834435-8CF459FD-67FF-4258-A50C-B3BBF03A4D8BQ36882535-CC2A9A1D-9E29-4F7A-BA30-B6DFBB8EB685Q36903075-0104E156-926F-4DA7-9556-A340E609D3B5Q37005082-A11F0864-5DC3-46E0-9276-71EADA97A06EQ37181181-8C803662-18FC-4A4E-A103-43AA3C0005F7Q37199236-E7CC768D-EDA0-4EE7-9829-0C70C3BEB227Q37514618-49E86C08-129C-4ED0-A7B9-6E6205C5D034Q37617482-0EEA5A19-FC7E-4042-9FBB-239A0295F5D0Q37733524-8845FA00-DE7C-46EC-9681-43DD552428BEQ37736648-9F3EF0BF-645C-49B3-9892-1B74E9A82898Q37885432-A09562A9-FE2B-44DB-93BD-75BE439F5E50Q38015754-29043B3E-3103-48F5-B852-D1AEF543E820Q38036926-F3C14602-9A76-4057-A062-E87C95B5FB60Q38056169-0A68D48D-CE46-4198-B594-87978D27CCFDQ38081040-A170DECA-0464-45A1-8A05-016F7C9BBCD9Q38153453-12FD388C-2A09-4E5F-85D9-300E70A56791Q38241636-E419556F-D67A-4B8A-ABD0-B03D42AF3F67Q38265919-D7E5AF61-0984-48DA-875D-B81249925B79Q38296706-0959FBB6-976E-4881-B73D-AE33E6933D05Q38317556-97D6DD6D-91D9-4DEA-849D-6D0B53341AC9Q38614953-CC95509C-7F06-40B1-9D34-04253342820A
P2860
Anaphylaxis: can we tell who is at risk of a fatal reaction?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Anaphylaxis: can we tell who is at risk of a fatal reaction?
@ast
Anaphylaxis: can we tell who is at risk of a fatal reaction?
@en
type
label
Anaphylaxis: can we tell who is at risk of a fatal reaction?
@ast
Anaphylaxis: can we tell who is at risk of a fatal reaction?
@en
prefLabel
Anaphylaxis: can we tell who is at risk of a fatal reaction?
@ast
Anaphylaxis: can we tell who is at risk of a fatal reaction?
@en
P1476
Anaphylaxis: can we tell who is at risk of a fatal reaction?
@en
P2093
Richard Pumphrey
P304
P356
10.1097/01.ALL.0000136762.89313.0B
P577
2004-08-01T00:00:00Z